Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
EDSA | US
0.03
0.74%
Healthcare
Biotechnology
30/06/2024
17/10/2024
4.10
4.21
4.29
4.01
Edesa Biotech Inc. a clinical-stage biopharmaceutical company engages in the research and development manufacture and commercialization of pharmaceutical products for inflammatory and immune-related diseases. Its lead product candidates are EB05 a monoclonal antibody which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in Covid-19 patients; and EB01 a topical vanishing cream containing non-steroidal anti-inflammatory compound that is in Phase 2b clinical study to treat chronic allergic contact dermatitis. The company also develops EB02 an extension of secretory phospholipase 2 anti-inflammatory cream for treating erythema swelling and exudation associated with hemorrhoids disease; and EB06 an anti- chemokine ligand 10 (CXCL10) monoclonal antibody in vitiligo. It has a collaboration agreement with NovImmune SA to develop monoclonal antibodies targeting products containing toll-like receptor 4 and CXCL10 for therapeutic prophylactic and diagnostic applications in humans and animals; and Yissum Research Development Company for the development of products for therapeutic prophylactic and diagnostic uses in topical dermal and anorectal applications as well as for the use in dermatologic and gastrointestinal conditions. The company was founded in 2015 and is headquartered in Markham Canada.
View LessStrength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
61.7%1 month
50.5%3 months
54.1%6 months
49.9%-
0.17
4.58
0.01
0.01
-1.25
128.53K
-
-8.27M
13.42M
13.42M
-
-
-
-99.90
-129.29
2.05
0.47
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.44
Range1M
1.00
Range3M
1.59
Rel. volume
2.09
Price X volume
107.42K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
IMNN | IMNN | Biotechnology | 0.9787 | 14.09M | -2.12% | n/a | 37.13% |
Aytu BioScience Inc | AYTU | Biotechnology | 2.29 | 14.08M | 0.11% | n/a | 54.59% |
Cingulate Inc. Common Stock | CING | Biotechnology | 4.49 | 13.67M | 2.05% | n/a | 10.72% |
NRXP | NRXP | Biotechnology | 1.265 | 13.60M | 2.85% | n/a | -46.73% |
Tenax Therapeutics Inc | TENX | Biotechnology | 3.9 | 13.60M | 2.63% | n/a | 3.14% |
Apollomics Inc. Class A Ordinary Shares | APLM | Biotechnology | 0.1232 | 13.55M | -1.36% | n/a | 21.43% |
Brainstorm Cell Therapeutics Inc | BCLI | Biotechnology | 2.43 | 12.92M | 11.47% | n/a | -27.28% |
KTRA | KTRA | Biotechnology | 0.2154 | 11.99M | -6.31% | n/a | 0.00% |
DOMH | DOMH | Biotechnology | 1.88 | 11.80M | -3.09% | n/a | 7.66% |
BioRestorative Therapies Inc | BRTX | Biotechnology | 1.6815 | 11.64M | -2.80% | n/a | 0.77% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a | |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.54 | 0 | -1.56% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -1.25 | 0.53 | Cheaper |
Ent. to Revenue | 128,525.00 | 4,005.99 | Expensive |
PE Ratio | - | 40.42 | - |
Price to Book | 4.58 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 54.08 | 72.92 | Lower Risk |
Debt to Equity | 0.01 | -1.24 | Expensive |
Debt to Assets | 0.01 | 0.25 | Cheaper |
Market Cap | 13.42M | 3.78B | Emerging |